Understanding the molecular basis of FOXO3a-induced suppression of cell growth and tumor development could also provide opportunities to develop innovative anticancer therapeutic modalities, such as small molecules that can activate FOXO3a, thereby potentially suppressing the growth of breast tumors and possibly preventing recurrence after therapy. Here, FOXO3 is linked to breast neoplasm.